Literature DB >> 8532603

Glucagon receptor mRNA distribution in rat tissues.

L H Hansen1, N Abrahamsen, E Nishimura.   

Abstract

In addition to glucagon's role in regulating glucose production from the liver, a number of extrahepatic effects of glucagon have been reported. We have therefore examined various rat tissues for glucagon receptor mRNA expression. In liver, kidney, heart, adipose tissue, spleen, pancreatic islets, ovary, and thymus, glucagon receptor mRNA expression was found to be relatively abundant whereas lower levels were detected in stomach, small intestine, adrenal gland, thyroid, and skeletal muscle. The presence of glucagon receptor mRNA in tissues known to be responsive to glucagon suggests that these effects are mediated by specific glucagon receptors. Furthermore, the finding of glucagon receptor mRNA in the spleen, thymus, thyroid, adrenal gland, ovary, and skeletal muscle, where glucagon is not generally considered to act, indicates that there may be novel actions of glucagon that have yet to be determined.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8532603     DOI: 10.1016/0196-9781(95)00078-x

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  21 in total

1.  Glucagon signalling in the dorsal vagal complex is sufficient and necessary for high-protein feeding to regulate glucose homeostasis in vivo.

Authors:  Mary P LaPierre; Mona A Abraham; Jessica T Y Yue; Beatrice M Filippi; Tony K T Lam
Journal:  EMBO Rep       Date:  2015-08-19       Impact factor: 8.807

2.  Ectopic expression of glucagon receptor in skeletal muscles improves glucose homeostasis in a mouse model of diabetes.

Authors:  A Maharaj; L Zhu; F Huang; H Qiu; H Li; C Y Zhang; T Jin; Q Wang
Journal:  Diabetologia       Date:  2012-02-09       Impact factor: 10.122

3.  Glucagon's effect on liver protein metabolism in vivo.

Authors:  Guillaume Kraft; Katie C Coate; Jason J Winnick; Dominique Dardevet; E Patrick Donahue; Alan D Cherrington; Phillip E Williams; Mary Courtney Moore
Journal:  Am J Physiol Endocrinol Metab       Date:  2017-05-23       Impact factor: 4.310

Review 4.  Glucagon action in the brain.

Authors:  Mona A Abraham; Tony K T Lam
Journal:  Diabetologia       Date:  2016-04-26       Impact factor: 10.122

5.  Effect of cobalt on the liver glycogen content in the streptozotocin-induced diabetic rats.

Authors:  Yasutomo Nomura; Shin-Ichiro Okamoto; Mitsuru Sakamoto; Zhonggang Feng; Takao Nakamura
Journal:  Mol Cell Biochem       Date:  2005-09       Impact factor: 3.396

6.  Hepatic Glucagon Receptor Signaling Enhances Insulin-Stimulated Glucose Disposal in Rodents.

Authors:  Teayoun Kim; Cassie L Holleman; Shelly Nason; Deanna M Arble; Nickki Ottaway; Joseph Chabenne; Christine Loyd; Jeong-A Kim; Darleen Sandoval; Daniel J Drucker; Richard DiMarchi; Diego Perez-Tilve; Kirk M Habegger
Journal:  Diabetes       Date:  2018-08-27       Impact factor: 9.461

7.  Dual elimination of the glucagon and GLP-1 receptors in mice reveals plasticity in the incretin axis.

Authors:  Safina Ali; Benjamin J Lamont; Maureen J Charron; Daniel J Drucker
Journal:  J Clin Invest       Date:  2011-04-11       Impact factor: 14.808

8.  Differential expression of glucagon and glucagon-like peptide 1 receptors in mouse pancreatic alpha and beta cells in two models of alpha cell hyperplasia.

Authors:  Mamdouh H Kedees; Marine Grigoryan; Yelena Guz; Gladys Teitelman
Journal:  Mol Cell Endocrinol       Date:  2009-07-30       Impact factor: 4.102

9.  Glucagon receptor inactivation leads to α-cell hyperplasia in zebrafish.

Authors:  Mingyu Li; E Danielle Dean; Liyuan Zhao; Wendell E Nicholson; Alvin C Powers; Wenbiao Chen
Journal:  J Endocrinol       Date:  2015-11       Impact factor: 4.286

10.  Disruption of glucagon receptor signaling causes hyperaminoacidemia exposing a possible liver-alpha-cell axis.

Authors:  Katrine D Galsgaard; Marie Winther-Sørensen; Cathrine Ørskov; Hannelouise Kissow; Steen S Poulsen; Hendrik Vilstrup; Cornelia Prehn; Jerzy Adamski; Sara L Jepsen; Bolette Hartmann; Jenna Hunt; Maureen J Charron; Jens Pedersen; Nicolai J Wewer Albrechtsen; Jens J Holst
Journal:  Am J Physiol Endocrinol Metab       Date:  2017-10-03       Impact factor: 4.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.